patients lrba deficiency show ctla4 loss immune dysregulation responsive abatacept therapy 
mutations lrba gene encoding lipopolysaccharide-responsive beige-like anchor protein cause syndrome autoimmunity lymphoproliferation humoral immune deficiency biological role lrba immunologic disease unknown found patients lrba deficiency manifested dramatic sustained improvement response abatacept ctla4 cytotoxic t lymphocyte antigen--immunoglobulin fusion drug clinical responses homology lrba proteins controlling intracellular trafficking led us hypothesize regulates ctla4 potent inhibitory immune receptor found lrba colocalized ctla4 endosomal vesicles lrba deficiency knockdown increased ctla4 turnover resulted reduced levels ctla4 protein foxp3+ regulatory activated conventional tcells lrba-deficient cells inhibition lysosome degradation chloroquine prevented ctla4 loss findings elucidate mechanism ctla4 trafficking control immune responses suggest therapies diseases involving ctla4 pathway 
